Zhende Medical Co., Ltd. (603301.SS)
- Previous Close
20.60 - Open
20.59 - Bid 20.62 x --
- Ask 20.65 x --
- Day's Range
20.38 - 20.82 - 52 Week Range
15.68 - 36.83 - Volume
1,491,324 - Avg. Volume
2,013,319 - Market Cap (intraday)
5.494B - Beta (5Y Monthly) --
- PE Ratio (TTM)
10.41 - EPS (TTM)
1.98 - Earnings Date --
- Forward Dividend & Yield 1.50 (5.83%)
- Ex-Dividend Date Oct 31, 2023
- 1y Target Est
28.00
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China. It offers stoma and modern wound care products, surgical infection control products, sensory control protection products, infection control protection products, basic wound care products, and pressure therapy and immobilization products, as well as medical-grade personal care and home health care products. The company sells its products approximately in 70 countries and regions in Europe, North America, Asia, South America, Africa, and Oceania. Zhende Medical Co., Ltd. was founded in 1994 and is headquartered in Shaoxing, China.
www.zhende.com8,027
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Related News
Performance Overview: 603301.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603301.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603301.SS
Valuation Measures
Market Cap
5.49B
Enterprise Value
4.51B
Trailing P/E
10.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.07
Price/Book (mrq)
1.00
Enterprise Value/Revenue
0.88
Enterprise Value/EBITDA
7.01
Financial Highlights
Profitability and Income Statement
Profit Margin
10.23%
Return on Assets (ttm)
6.89%
Return on Equity (ttm)
9.74%
Revenue (ttm)
5.15B
Net Income Avi to Common (ttm)
526.61M
Diluted EPS (ttm)
1.98
Balance Sheet and Cash Flow
Total Cash (mrq)
1.68B
Total Debt/Equity (mrq)
12.22%
Levered Free Cash Flow (ttm)
626.13M
Research Analysis: 603301.SS
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 603301.SS
603301.SS does not have Company Insights